Found: 5
Select item for more details and to access through your institution.
Impact of Age Group on Febrile Neutropenia Risk Assessment and Management in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP Regimens.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 297, doi. 10.1016/j.clml.2012.06.004
- By:
- Publication type:
- Article
Evaluation of the GELTAMO guidelines for surveillance in follicular lymphomas after first‐line immunochemotherapy: a real‐world prospective study.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 386, doi. 10.1002/hon.3164_280
- By:
- Publication type:
- Article
LENALIDOMIDE PLUS R‐GDP (R2‐GDP) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA. PRELIMINARY RESULTS OF THE R2‐GDP‐GOTEL TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 258, doi. 10.1002/hon.67_2630
- By:
- Publication type:
- Article
LENALIDOMIDE PLUS R‐GDP (R2‐GDP) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA. PRELIMINARY RESULTS OF THE R2‐GDP‐GOTEL TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 258, doi. 10.1002/hon.67_2630
- By:
- Publication type:
- Article
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDPGOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1293931
- By:
- Publication type:
- Article